Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

10

Revenue 2017

Lyrica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lyrica was produced by Pfizer and Eisai.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era

These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December. ... autonomous. Created in the summer reshuffle, the Established Medicines division

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires Nevertheless, the new CEO will undoubtedly consider the M&A market once he takes over in 2019, not least because of impending generic threats to $4bn a year blockbuster Lyrica sales

Pfizer builds gap between pharma and consumer health units

Pfizer builds gap between pharma and consumer health units The last of these – epilepsy therapy Lyrica (pregabalin) – will be exposed to generic competition in the US from December of this year, he said.

The good, the bad and the ugly

The good, the bad and the ugly Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.

Pfizer drops neuroscience R&D, cutting 300 jobs

Pfizer drops neuroscience R&D, cutting 300 jobs chronic pain associated with osteoarthritis Lyrica (pregabalin) for fibromyalgia, as well as CNS-targeting drugs in its rare disease programme.

1 2 3 4 5 6 7 8 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics